These are the sources and citations used to research Module 6 Week 4 Case 2. This bibliography was generated on Cite This For Me on

  • Journal

    Bastuji-Garin, S., Rzany, B., Stern, R. S., Shear, N. H. and Naidi, L.

    Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme

    1993 - Archives of Dermatology

    In-text: (Bastuji-Garin et al. 92-96)

    Your Bibliography: Bastuji-Garin, S. et al. "Clinical Classification Of Cases Of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, And Erythema Multiforme." Archives of Dermatology 129.1 (1993): 92-96. Web.

  • Journal

    Collins, L. K., Chapman, M. S., Carter, J. B. and Samie, F. H.

    Cutaneous adverse effects of the immune checkpoint inhibitors

    2017 - Current Problems in Cancer

    In-text: (Collins et al. 125-128)

    Your Bibliography: Collins, Lindsey K. et al. "Cutaneous Adverse Effects Of The Immune Checkpoint Inhibitors." Current Problems in Cancer 41.2 (2017): 125-128. Web. 29 Jan. 2020.

  • Journal

    Creamer, D., Walsh, S., Dziewulski, P., Exton, L. and Lee, H.

    U.K. guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults 2016

    2016 - British Journal of Dermatology

    In-text: (Creamer et al. 1194-1227)

    Your Bibliography: Creamer, D. et al. "U.K. Guidelines For The Management Of Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis In Adults 2016." British Journal of Dermatology 174.6 (2016): 1194-1227. Web. 29 Jan. 2020.

  • Journal

    Dorafshar, A. H., Dickie, S. R., Cohn, A. B., Aycock, J. K. and O’Connor, A.

    Antishear Therapy for Toxic Epidermal Necrolysis: An Alternative Treatment Approach

    2008 - Plastic and Reconstructive Surgery

    In-text: (Dorafshar et al. 154-160)

    Your Bibliography: Dorafshar, Amir H. et al. "Antishear Therapy For Toxic Epidermal Necrolysis: An Alternative Treatment Approach." Plastic and Reconstructive Surgery 122.1 (2008): 154-160. Web. 29 Jan. 2020.

  • Journal

    Ferrandiz-Pulido, C. and Garcia-Patos, V.

    A review of causes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children

    2013 - Archives of Disease in Childhood

    In-text: (Ferrandiz-Pulido and Garcia-Patos 998-1003)

    Your Bibliography: Ferrandiz-Pulido, C., and V. Garcia-Patos. "A Review Of Causes Of Stevens-Johnson Syndrome And Toxic Epidermal Necrolysis In Children." Archives of Disease in Childhood 98.12 (2013): 998-1003. Web. 29 Jan. 2020.

  • Website

    Foster, C. S.

    Stevens-Johnson Syndrome

    2020 - Medscape

    In-text: (Foster)

    Your Bibliography: Foster, C Stephen. "Stevens-Johnson Syndrome." Medscape. N.p., 2020. Web. 29 Jan. 2020.

  • Journal

    Fouchard, N., Bertocchi, M., Roujeau, J., Revuz, J. and Wolkenstein, P.

    SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis

    2000 - Journal of Investigative Dermatology

    In-text: (Fouchard et al. 149-153)

    Your Bibliography: Fouchard, Nathalie et al. "SCORTEN: A Severity-Of-Illness Score For Toxic Epidermal Necrolysis." Journal of Investigative Dermatology 115.2 (2000): 149-153. Web. 29 Jan. 2020.

  • Journal

    Halevy, S., Ghislain, P., Mockenhaupt, M., Fagot, J. and Bouwes Bavinck, J. N.

    Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel

    2008 - Journal of the American Academy of Dermatology

    In-text: (Halevy et al. 25-32)

    Your Bibliography: Halevy, Sima et al. "Allopurinol Is The Most Common Cause Of Stevens-Johnson Syndrome And Toxic Epidermal Necrolysis In Europe And Israel." Journal of the American Academy of Dermatology 58.1 (2008): 25-32. Web. 29 Jan. 2020.

  • Website

    High, W. A.

    Stevens-Johnson syndrome and toxic epidermal necrolysis: Management, prognosis, and long-term sequelae

    2019 - UpToDate

    In-text: (High)

    Your Bibliography: High, Whitney A. "Stevens-Johnson Syndrome And Toxic Epidermal Necrolysis: Management, Prognosis, And Long-Term Sequelae." UpToDate. N.p., 2019. Web. 29 Jan. 2020.

  • Website

    High, W. A.

    Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis

    2019 - UpToDate

    In-text: (High)

    Your Bibliography: High, Whitney A. "Stevens-Johnson Syndrome And Toxic Epidermal Necrolysis: Pathogenesis, Clinical Manifestations, And Diagnosis." UpToDate. N.p., 2019. Web. 29 Jan. 2020.

  • Book

    Hui, D., Leung, A. K. C. and Padwal, R.

    Approach to Internal Medicine: A Resource Book for Clinical Practice

    2016 - Springer - Houston

    In-text: (Hui, Leung and Padwal)

    Your Bibliography: Hui, David, Alexander K. C Leung, and Raj Padwal. Approach To Internal Medicine: A Resource Book For Clinical Practice. 4th ed. Houston: Springer, 2016. Print.

  • Journal

    Letko, E., Papaliodis, D. N., Papaliodis, G. N., Daoud, Y. J. and Ahmed, A. R.

    Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature

    2005 - Annals of Allergy, Asthma & Immunology

    In-text: (Letko et al. 419-436)

    Your Bibliography: Letko, Erik et al. "Stevens-Johnson Syndrome And Toxic Epidermal Necrolysis: A Review Of The Literature." Annals of Allergy, Asthma & Immunology 94.4 (2005): 419-436. Web. 29 Jan. 2020.

  • Journal

    Mockenhaupt, M., Viboud, C., Dunant, A., Naldi, L. and Halevy, S.

    Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

    2008 - Journal of Investigative Dermatology

    In-text: (Mockenhaupt et al. 35-44)

    Your Bibliography: Mockenhaupt, Maja et al. "Stevens–Johnson Syndrome And Toxic Epidermal Necrolysis: Assessment Of Medication Risks With Emphasis On Recently Marketed Drugs. The Euroscar-Study." Journal of Investigative Dermatology 128.1 (2008): 35-44. Web. 29 Jan. 2020.

  • Journal

    Revuz, J.

    Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients

    1987 - Archives of Dermatology

    In-text: (Revuz 1160-1165)

    Your Bibliography: Revuz, J. "Toxic Epidermal Necrolysis. Clinical Findings And Prognosis Factors In 87 Patients." Archives of Dermatology 123.9 (1987): 1160-1165. Web. 29 Jan. 2020.

  • Journal

    Roujeau, J., Chosidow, O., Saiag, P. and Guillaume, J.

    Toxic epidermal necrolysis (Lyell syndrome)

    1990 - Journal of the American Academy of Dermatology

    In-text: (Roujeau et al. 1039-1058)

    Your Bibliography: Roujeau, Jean-Claude et al. "Toxic Epidermal Necrolysis (Lyell Syndrome)." Journal of the American Academy of Dermatology 23.6 (1990): 1039-1058. Web. 29 Jan. 2020.

  • Journal

    Roujeau, J.

    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Are Severity Variants of the Same Disease which Differs from Erythema Multiforme

    1997 - The Journal of Dermatology

    In-text: (Roujeau 726-729)

    Your Bibliography: Roujeau, Jean-Claude. "Stevens-Johnson Syndrome And Toxic Epidermal Necrolysis Are Severity Variants Of The Same Disease Which Differs From Erythema Multiforme." The Journal of Dermatology 24.11 (1997): 726-729. Web. 29 Jan. 2020.

  • Journal

    Sassolas, B., Haddad, C., Mockenhaupt, M., Dunant, A. and Liss, Y.

    ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis

    2010 - Clinical Pharmacology & Therapeutics

    In-text: (Sassolas et al. 60-68)

    Your Bibliography: Sassolas, B et al. "ALDEN, An Algorithm For Assessment Of Drug Causality In Stevens–Johnson Syndrome And Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis." Clinical Pharmacology & Therapeutics 88.1 (2010): 60-68. Web. 29 Jan. 2020.

  • Journal

    Schwartz, R. A., McDonough, P. H. and Lee, B. W.

    Toxic epidermal necrolysis

    2013 - Journal of the American Academy of Dermatology

    In-text: (Schwartz, McDonough and Lee 187.e1-187.e16)

    Your Bibliography: Schwartz, Robert A., Patrick H. McDonough, and Brian W. Lee. "Toxic Epidermal Necrolysis." Journal of the American Academy of Dermatology 69.2 (2013): 187.e1-187.e16. Web. 29 Jan. 2020.

  • Journal

    Shiga, S. and Cartotto, R.

    What Are the Fluid Requirements in Toxic Epidermal Necrolysis?

    2010 - Journal of Burn Care & Research

    In-text: (Shiga and Cartotto 100-104)

    Your Bibliography: Shiga, Sarah, and Rob Cartotto. "What Are The Fluid Requirements In Toxic Epidermal Necrolysis?." Journal of Burn Care & Research 31.1 (2010): 100-104. Web. 29 Jan. 2020.

  • Journal

    Spies, M., Sanford, A. P., Low, J. F. A., Wolf, S. E. and Herndon, D. N.

    Treatment of Extensive Toxic Epidermal Necrolysis in Children

    2001 - PEDIATRICS

    In-text: (Spies et al. 1162-1168)

    Your Bibliography: Spies, M. et al. "Treatment Of Extensive Toxic Epidermal Necrolysis In Children." PEDIATRICS 108.5 (2001): 1162-1168. Web. 29 Jan. 2020.

  • Journal

    Stern, R. S. and Divito, S. J.

    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology—Thirty Years of Progress but Still Much to Be Done

    2017 - Journal of Investigative Dermatology

    In-text: (Stern and Divito 1004-1008)

    Your Bibliography: Stern, Robert S., and Sherrie J. Divito. "Stevens-Johnson Syndrome And Toxic Epidermal Necrolysis: Associations, Outcomes, And Pathobiology—Thirty Years Of Progress But Still Much To Be Done." Journal of Investigative Dermatology 137.5 (2017): 1004-1008. Web. 29 Jan. 2020.

  • Journal

    Vivar, K. L., Deschaine, M., Messina, J., Divine, J. M. and Rabionet, A.

    Epidermal programmed cell death‐ligand 1 expression in TEN associated with nivolumab therapy

    2017 - Journal of Cutaneous Pathology

    In-text: (Vivar et al. 381-384)

    Your Bibliography: Vivar, Karina L. et al. "Epidermal Programmed Cell Death‐Ligand 1 Expression In TEN Associated With Nivolumab Therapy." Journal of Cutaneous Pathology 44.4 (2017): 381-384. Web. 29 Jan. 2020.

  • Journal

    Wetter, D. A. and Camilleri, M. J.

    Clinical, Etiologic, and Histopathologic Features of Stevens-Johnson Syndrome During an 8-Year Period at Mayo Clinic

    2010 - Mayo Clinic Proceedings

    In-text: (Wetter and Camilleri 131-138)

    Your Bibliography: Wetter, David A., and Michael J. Camilleri. "Clinical, Etiologic, And Histopathologic Features Of Stevens-Johnson Syndrome During An 8-Year Period At Mayo Clinic." Mayo Clinic Proceedings 85.2 (2010): 131-138. Web. 29 Jan. 2020.

Click here to start building your own bibliography
Keep on Citing!
Cite This For Me:
The Easiest Tool to Create your Bibliographies Online
Join Us!

Save Time and Improve Your Marks with Cite This For Me

10,587 students joined last month!

  • ✔ Save your bibliographies for longer
  • ✔ Super fast and accurate citation program
  • ✔ Save time when referencing
  • ✔ Make your student life easy and fun
  • ✔ Pay only once with our Forever plan
  • ✔ Use plagiarism checker
  • ✔ Create and edit multiple bibliographies
Join